C. Austin, D. Maziere, A. Pisacane, P. Van-dijk, S. Eigenbrot et al., Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin, Molecular Biology of the Cell, vol.15, issue.12, pp.5268-5282, 2004.
DOI : 10.1091/mbc.E04-07-0591

C. Benn, H. Fox, and G. Bates, Optimisation of region-specific reference gene selection and relative gene expression analysis methods for preclinical trials of Huntington's disease, Mol Neurodegener, vol.3, pp.1-17, 2008.

M. Borrell-pages, D. Zala, S. Humbert, and F. Saudou, Huntington?s disease: from huntingtin function and dysfunction to therapeutic strategies, Cellular and Molecular Life Sciences, vol.63, issue.22, pp.2642-2660, 2006.
DOI : 10.1007/s00018-006-6242-0

A. Brunet, S. Datta, and M. Greenberg, Transcription-dependent and -independent control of neuronal survival by the PI3K?Akt signaling pathway, Current Opinion in Neurobiology, vol.11, issue.3, pp.297-305, 2001.
DOI : 10.1016/S0959-4388(00)00211-7

C. Castaneda, H. Cortes-funes, H. Gomez, and E. Ciruelos, The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer, Cancer and Metastasis Reviews, vol.23, issue.23, pp.751-759, 2010.
DOI : 10.1158/0008-5472.SABCS-3061

J. Caviston, J. Ross, S. Antony, M. Tokito, and E. Holzbaur, Huntingtin facilitates dynein/dynactin-mediated vesicle transport, Proceedings of the National Academy of Sciences, vol.276, issue.39, pp.10045-10050, 2007.
DOI : 10.1074/jbc.M104838200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891230

W. Cheng, J. Kandel, D. Yamashiro, P. Canoll, and D. Anastassiou, A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma, PLoS ONE, vol.9, issue.4, p.34705, 2012.
DOI : 10.1371/journal.pone.0034705.t004

A. Citri, B. Kochupurakkal, and Y. Yarden, The Achilles Heel of ErbB-2/HER2: Regulation by the Hsp90 Chaperone Machine and Potential for Pharmacological Intervention, Cell Cycle, vol.3, issue.1, pp.51-60, 2004.
DOI : 10.4161/cc.3.1.607

E. Colin, E. Regulier, V. Perrin, A. Durr, A. Brice et al., Akt is altered in an animal model of Huntington's disease and in patients, European Journal of Neuroscience, vol.293, issue.6, pp.1478-1488, 2005.
DOI : 10.1016/S0168-9525(03)00074-X

V. Dangles-marie, Establishment of Human Colon Cancer Cell Lines from Fresh Tumors versus Xenografts: Comparison of Success Rate and Cell Line Features, Cancer Research, vol.67, issue.1, pp.398-407, 2007.
DOI : 10.1158/0008-5472.CAN-06-0594

M. Difiglia, Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons, Neuron, vol.14, issue.5, pp.1075-1081, 1995.
DOI : 10.1016/0896-6273(95)90346-1

R. Dillon and W. Muller, Distinct Biological Roles for the Akt Family in Mammary Tumor Progression, Cancer Research, vol.70, issue.11, pp.4260-4264, 2010.
DOI : 10.1158/0008-5472.CAN-10-0266

M. Duyao, Inactivation of the mouse Huntington's disease gene homolog Hdh, Science, vol.269, issue.5222, pp.407-410, 1995.
DOI : 10.1126/science.7618107

S. Eccles, The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology, The International Journal of Developmental Biology, vol.55, issue.7-8-9, pp.685-696, 2011.
DOI : 10.1387/ijdb.113396se

L. Gauthier, Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules, Cell, vol.118, issue.1, pp.127-138, 2004.
DOI : 10.1016/j.cell.2004.06.018

S. Gines, E. Ivanova, I. Seong, C. Saura, and M. Macdonald, -Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells, Journal of Biological Chemistry, vol.1366, issue.50, pp.50514-50522, 2003.
DOI : 10.1016/S0896-6273(03)00366-0
URL : https://hal.archives-ouvertes.fr/hal-00122183

J. Godin, Huntingtin Is Required for Mitotic Spindle Orientation and Mammalian Neurogenesis, Neuron, vol.67, issue.3, pp.392-406, 2010.
DOI : 10.1016/j.neuron.2010.06.027
URL : http://doi.org/10.1016/j.neuron.2010.06.027

C. Guy, R. Cardiff, and W. Muller, Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease., Molecular and Cellular Biology, vol.12, issue.3, pp.954-961, 1992.
DOI : 10.1128/MCB.12.3.954

P. Harjes and E. Wanker, The hunt for huntingtin function: interaction partners tell many different stories, Trends in Biochemical Sciences, vol.28, issue.8, pp.425-433, 2003.
DOI : 10.1016/S0968-0004(03)00168-3

A. Hoogeveen, R. Willemsen, N. Meyer, K. De-rooij, R. Roos et al., Characterization and localization of the Huntington disease gene product, Human Molecular Genetics, vol.2, issue.12, pp.2069-2073, 1993.
DOI : 10.1093/hmg/2.12.2069

S. Humbert, E. Bryson, F. Cordelieres, N. Connors, S. Datta et al., The IGF-1/Akt Pathway Is Neuroprotective in Huntington's Disease and Involves Huntingtin Phosphorylation by Akt, Developmental Cell, vol.2, issue.6, pp.831-837, 2002.
DOI : 10.1016/S1534-5807(02)00188-0

J. Ji, K. Sundquist, and J. Sundquist, Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden, The Lancet Oncology, vol.13, issue.6, pp.642-648, 2012.
DOI : 10.1016/S1470-2045(12)70132-8

L. Kaltenbach, Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration, PLoS Genetics, vol.13, issue.5, p.82, 2007.
DOI : 10.1371/journal.pgen.0030082.st005
URL : http://doi.org/10.1371/journal.pgen.0030082

K. Kegel, Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription, Journal of Biological Chemistry, vol.21, issue.9, pp.7466-7476, 2002.
DOI : 10.1006/mcne.2001.1004

K. Kegel, Huntingtin Associates with Acidic Phospholipids at the Plasma Membrane, Journal of Biological Chemistry, vol.26, issue.43, pp.36464-36473, 2005.
DOI : 10.1002/elps.1150181505

H. Kim, J. Watkinson, V. Varadan, and D. Anastassiou, Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1, BMC Medical Genomics, vol.177, issue.1, pp.1-11, 2010.
DOI : 10.2353/ajpath.2010.100105

M. Landis, D. Seachrist, F. Karim, and R. Keri, Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors, Oncogene, vol.63, issue.23, pp.3325-3334, 2006.
DOI : 10.1128/MCB.14.11.7068

S. Li and X. Li, Huntingtin?protein interactions and the pathogenesis of Huntington's disease, Trends in Genetics, vol.20, issue.3, pp.146-154, 2004.
DOI : 10.1016/j.tig.2004.01.008

J. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman, Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila, Human Molecular Genetics, vol.14, issue.5, pp.713-724, 2005.
DOI : 10.1093/hmg/ddi067
URL : https://hal.archives-ouvertes.fr/hal-00118469

. Research-article-www, embomolmed.org Huntington's disease and breast cancer ß 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO, EMBO Mol Med, vol.5, pp.309-325, 2013.

Y. Liu, R. Deth, and D. Devys, SH3 Domain-dependent Association of Huntingtin with Epidermal Growth Factor Receptor Signaling Complexes, Journal of Biological Chemistry, vol.15, issue.13, pp.8121-8124, 1997.
DOI : 10.1006/exnr.1995.1029

A. Lumsden, T. Henshall, S. Dayan, M. Lardelli, and R. Richards, Huntingtin-deficient zebrafish exhibit defects in iron utilization and development, Human Molecular Genetics, vol.16, issue.16, pp.1905-1920, 2007.
DOI : 10.1093/hmg/ddm138

L. Menalled, Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models, Neurobiology of Disease, vol.35, issue.3, pp.319-336, 2009.
DOI : 10.1016/j.nbd.2009.05.007

M. Metzler, C. Helgason, I. Dragatsis, T. Zhang, L. Gan et al., Huntingtin is required for normal hematopoiesis, Human Molecular Genetics, vol.9, issue.3, pp.387-394, 2000.
DOI : 10.1093/hmg/9.3.387

F. Mochel, Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression, PLoS ONE, vol.21, issue.7, p.647, 2007.
DOI : 10.1371/journal.pone.0000647.t002

C. Morton and P. Houghton, Establishment of human tumor xenografts in immunodeficient mice, Nature Protocols, vol.46, issue.2, pp.247-250, 2007.
DOI : 10.1038/nprot.2007.25

W. Muller, E. Sinn, P. Pattengale, R. Wallace, and P. Leder, Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene, Cell, vol.54, issue.1, pp.105-115, 1988.
DOI : 10.1016/0092-8674(88)90184-5

J. Nasir, S. Floresco, O. Kusky, J. Diewert, V. Richman et al., Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell, vol.81, issue.5, pp.811-823, 1995.
DOI : 10.1016/0092-8674(95)90542-1

R. Pardo, C. E. Regulier, E. Aebischer, P. Deglon, N. Humbert et al., Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421, Journal of Neuroscience, vol.26, issue.5, pp.1635-1645, 2006.
DOI : 10.1523/JNEUROSCI.3706-05.2006

R. Pardo, M. Molina-calavita, G. Poizat, G. Keryer, S. Humbert et al., pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking, Molecular Brain, vol.3, issue.1, pp.1-17, 2010.
DOI : 10.1186/1756-6606-3-17
URL : http://doi.org/10.1186/1756-6606-3-17

N. Pedersen, I. Madshus, C. Haslekas, and E. Stang, Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent, Molecular Cancer Research, vol.6, issue.3, pp.491-500, 2008.
DOI : 10.1158/1541-7786.MCR-07-0191

M. Pouladi, Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression, Human Molecular Genetics, vol.19, issue.8, pp.1528-1538, 2010.
DOI : 10.1093/hmg/ddq026
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846162

K. Roepstorff, L. Grovdal, M. Grandal, M. Lerdrup, and B. Van-deurs, Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer, Histochemistry and Cell Biology, vol.278, issue.Suppl 2, pp.563-578, 2008.
DOI : 10.1091/mbc.10.5.1621

N. Saleh, S. Moutereau, A. Durr, P. Krystkowiak, J. Azulay et al., Neuroendocrine Disturbances in Huntington's Disease, PLoS ONE, vol.156, issue.3, p.4962, 2009.
DOI : 10.1371/journal.pone.0004962.t004

J. Sassone, C. Colciago, G. Cislaghi, V. Silani, and A. Ciammola, Huntington's disease: The current state of research with peripheral tissues, Experimental Neurology, vol.219, issue.2, pp.385-397, 2009.
DOI : 10.1016/j.expneurol.2009.05.012

J. Simpson, J. Gil-mohapel, M. Pouladi, M. Ghilan, Y. Xie et al., Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease, Neurobiology of Disease, vol.41, issue.2, pp.249-260, 2011.
DOI : 10.1016/j.nbd.2010.09.012

C. Song, G. Perides, and Y. Liu, Expression of Full-length Polyglutamine-expanded Huntingtin Disrupts Growth Factor Receptor Signaling in Rat Pheochromocytoma (PC12) Cells, Journal of Biological Chemistry, vol.49, issue.8, pp.6703-6707, 2002.
DOI : 10.1016/S0092-8674(00)81883-8

S. Sorensen, K. Fenger, and J. Olsen, Significantly lower incidence of cancer among patients with Huntington disease, Cancer, vol.86, issue.7, pp.1342-1346, 1999.
DOI : 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V

A. Sorkin and L. Goh, Endocytosis and intracellular trafficking of ErbBs, Experimental Cell Research, vol.315, issue.4, pp.3093-3106, 2008.
DOI : 10.1016/j.yexcr.2008.07.029

Y. Trottier, D. Devys, G. Imbert, F. Saudou, I. An et al., Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form, Nature Genetics, vol.84, issue.1, pp.104-110, 1995.
DOI : 10.1038/334345a0

J. Van-der-burg, M. Bjorkqvist, and P. Brundin, Beyond the brain: widespread pathology in Huntington's disease, The Lancet Neurology, vol.8, issue.8, pp.765-774, 2009.
DOI : 10.1016/S1474-4422(09)70178-4

J. Velier, M. Kim, C. Schwarz, T. Kim, E. Sapp et al., Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways, Experimental Neurology, vol.152, issue.1, pp.34-40, 1998.
DOI : 10.1006/exnr.1998.6832

S. Warby, E. Chan, M. Metzler, L. Gan, R. Singaraja et al., Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo, Human Molecular Genetics, vol.14, issue.11, pp.1569-1577, 2005.
DOI : 10.1093/hmg/ddi165

V. Wheeler, Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse, Human Molecular Genetics, vol.8, issue.1, pp.115-122, 1999.
DOI : 10.1093/hmg/8.1.115

J. White, W. Auerbach, M. Duyao, J. Vonsattel, J. Gusella et al., Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion, Nature Genetics, vol.90, issue.4, pp.404-410, 1997.
DOI : 10.1016/0006-8993(88)90055-8

J. Woda, T. Calzonetti, P. Hilditch-maguire, M. Duyao, R. Conlon et al., Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo, BMC Dev Biol, vol.5, pp.1-17, 2005.

Y. Yarden and M. Sliwkowski, Untangling the ErbB signalling network, Nature Reviews Molecular Cell Biology, vol.2, issue.2, pp.127-137, 2001.
DOI : 10.1038/35052073

D. Zala, C. E. Rangone, H. Liot, G. Humbert, S. Saudou et al., Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons, Human Molecular Genetics, vol.17, issue.24, pp.3837-3846, 2008.
DOI : 10.1093/hmg/ddn281

S. Zeitlin, J. Liu, D. Chapman, V. Papaioannou, and A. Efstratiadis, Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue, Nature Genetics, vol.3, issue.2, pp.155-163, 1995.
DOI : 10.1101/gr.3.6.S113

H. Zoghbi and H. Orr, Glutamine Repeats and Neurodegeneration, Annual Review of Neuroscience, vol.23, issue.1, pp.217-247, 2000.
DOI : 10.1146/annurev.neuro.23.1.217

C. Zuccato, Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes, Nature Genetics, vol.35, issue.1, pp.76-83, 2003.
DOI : 10.1038/ng1219

C. Zuccato, M. Valenza, and E. Cattaneo, Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease, Physiological Reviews, vol.90, issue.3, pp.905-981, 2010.
DOI : 10.1152/physrev.00041.2009